Jhunjhunwala#39;s RARE Trusts-backed Concord Biotech IPO booked 16% on debut
InnfotainmentAugust 04, 2023
0
Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer.
http://dlvr.it/StB3CN